The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.
The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.
Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.
“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”
The capacity to burn coal for power went up in 2022 despite global promises to phase down the fuel that’s the biggest source of planet-warming gases in the atmosphere, a report Wednesday found.
Dr. Sandra Lee (aka Dr. Pimple Popper) visited Cheddar News to give viewers a sneak peak of season nine of her TV show, which features the dermatologist popping — you guessed it — pimples.
According to a Washington Post article, 82 percent of people get their weather updates on their phones, and there are more than 10,000 weather apps to choose from. The article breaks down the pros and cons of each app.
Some 9.2 million lead pipes carry water into homes across the U.S., with more in Florida than any other state, according to a new Environmental Protection Agency survey that will dictate how billions of dollars to find and replace those pipes are spent.
